| http://www.w3.org/ns/prov#value | - It still needs to be determined whether or not PGRN mutations are responsible for other clinical or pathological conditions (such as other types of dementia or MND) and whether polymorphisms in PGRN are risk factors for sporadic FTD or other conditions.
|
